1. Home
  2. EQR vs IQV Comparison

EQR vs IQV Comparison

Compare EQR & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Equity Residential of Beneficial Interest

EQR

Equity Residential of Beneficial Interest

HOLD

Current Price

$67.87

Market Cap

24.3B

Sector

Real Estate

ML Signal

HOLD

Logo IQVIA Holdings Inc.

IQV

IQVIA Holdings Inc.

HOLD

Current Price

$186.82

Market Cap

28.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EQR
IQV
Founded
1993
1982
Country
United States
United States
Employees
N/A
93000
Industry
Real Estate Investment Trusts
Biotechnology: Commercial Physical & Biological Resarch
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.3B
28.6B
IPO Year
1994
2013

Fundamental Metrics

Financial Performance
Metric
EQR
IQV
Price
$67.87
$186.82
Analyst Decision
Buy
Strong Buy
Analyst Count
13
16
Target Price
$69.63
$227.13
AVG Volume (30 Days)
2.5M
1.5M
Earning Date
04-28-2026
05-05-2026
Dividend Yield
4.29%
N/A
EPS Growth
8.09
4.67
EPS
0.24
1.61
Revenue
$2,701,075,000.00
$9,739,000,000.00
Revenue This Year
$4.07
$6.77
Revenue Next Year
$3.14
$5.89
P/E Ratio
$275.58
$113.07
Revenue Growth
4.76
41.60
52 Week Low
$57.57
$151.58
52 Week High
$70.21
$247.05

Technical Indicators

Market Signals
Indicator
EQR
IQV
Relative Strength Index (RSI) 62.84 61.56
Support Level $63.76 $176.99
Resistance Level N/A $191.78
Average True Range (ATR) 1.19 6.96
MACD -0.07 1.57
Stochastic Oscillator 89.50 87.61

Price Performance

Historical Comparison
EQR
IQV

About EQR Equity Residential of Beneficial Interest

Equity Residential owns a portfolio of 318 apartment communities with over 86,000 units and is developing three additional properties with 935 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.

About IQV IQVIA Holdings Inc.

Iqvia is a global leader in clinical research and technology solutions for the life science industry. Formed in 2016 from the merger of Quintiles and IMS Health, it combined clinical trial services with extensive healthcare data and analytics. Its reserach and development solutions segment provides outsourced clinical development services spanning drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies optimize product commercialization through analytics, technology, and outsourced sales and medical services. Together, Iqvia supports customers across the life science industry, and it serves biopharmaceutical firms, providers, payers, and policymakers.

Share on Social Networks: